Substance-Related Disorder clinical trials
12 active trials name this condition. Describe your situation to see which ones you may be eligible for.
- Parent SMART (Substance Misuse in Adolescents in Residential Treatment)
- Improving Alcohol and Substance Use Care Access, Outcome, Equity During the Reproductive Years
- Testing Implementation Strategies to Scale-up a Multicomponent Continuum of Service Intervention for Families Involved in Systems With Parental Opioid and Methamphetamine Use
- Phase II: Scalable Digital Delivery of CRAFT Training for Professionals to Maximize Treatment Rates of OUD in Families
- Evaluating an Adverse Childhood Experience-Targeting Advocate Model of a Substance Use Prevention Program
- Motivational Interviewing at Intake vs Intake as Usual on Client Engagement in Addiction Treatment
- Prescribe to Prevent HIV: A Hybrid Trial Helping Addiction Clinics Prevent HIV & Infections Through Safer Drug Use Support
- Fatal Overdose Review Teams - Research to Enhance Surveillance Systems
- Expression of Stress Markers During Meth Treatment (EXPRESS+)
- Disrupting SRFOH to Improve Substance Use and Mental Health Outcomes for Parents in Rural Regions
- CRP and S&A for Inpatient Veterans
- Feasibility of the 5-Step Method in the U.S.
Guides for people searching for a trial
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.
Showing active trials that list “Substance-Related Disorder” as a condition. Eligibility shown on each trial is an estimate — the trial's study team makes the final decision.